IMARC Group’s report titled “Orthobiologics Market Report by Product (Demineralized Bone Matrix, Allograft, Bone Morphogenetic Protein, Viscosupplementation Products, Synthetic Bone Substitutes, and Others), Type (Knee, Ankle, Hip, Wrist and Shoulder, Spine, and Others), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, Maxillofacial and Dental Applications), End User (Hospitals and Ambulatory Centers, Research and Academic Institutes, Dental Clinics and Facilities, Orthopedic Clinics), and Region 2024-2032”, The global orthobiologics market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
Factors Affecting the Growth of the Orthobiologics Industry:
- Aging Population and Rising Orthopedic Conditions:
In 2024, the orthobiologics market is growing rapidly due to the aging population and the increase in orthopedic conditions like osteoarthritis and degenerative disc disease. As people age, their bones and joints are more likely to wear down, leading to a higher demand for minimally invasive and regenerative therapies. Orthobiologics, which use the body’s natural healing process, offer promising treatments for these conditions, driving market growth. - Advancements in Regenerative Medicine:
Regenerative medicine is advancing quickly, and in 2024, there are major improvements in orthobiologics. Researchers are developing new therapies like stem cell therapy and tissue engineering that could change how orthopedic injuries and diseases are treated. These therapies aim to repair damaged tissues and improve healing, leading to better outcomes for patients and more demand for orthobiologic products. - Growing Preference for Minimally Invasive Procedures:
In 2024, there is a strong trend toward minimally invasive procedures in orthopedic surgeries. These treatments have advantages like less pain, shorter recovery times, and lower risks of complications. Orthobiologics are key in these procedures by helping tissues heal quickly and reducing the need for major surgeries. This trend is increasing the demand for orthobiologics.
Grab a sample PDF of this report: https://www.imarcgroup.com/orthobiologics-market/requestsample
Leading Companies Operating in the Global Orthobiologics Industry:
- Arthrex Inc
- Globus Medical Inc.
- Integra LifeSciences
- Johnson & Johnson
- Medline Industries Inc.
- Medtronic plc
- NuVasive Inc
- Orthofix Medical Inc.
- Smith & Nephew plc
- Stryker Corporation
- Terumo Corporation
- Wright Medical Group N.V.
- Zimmer Biomet
Orthobiologics Market Report Segmentation:
By Product:
- Demineralized Bone Matrix
- Allograft
- Bone Morphogenetic Protein
- Viscosupplementation Products
- Synthetic Bone Substitutes
- Others
Viscosupplementation products represent the largest segment as it helps in restoring the viscoelastic properties of synovial fluid and reducing pain.
By Type:
- Knee
- Ankle
- Hip
- Wrist and Shoulder
- Spine
- Others
Knee holds the biggest market share due to the rising prevalence of knee osteoarthritis.
By Application:
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Fracture Recovery
- Soft Tissue Injuries
- Maxillofacial and Dental Applications
Osteoarthritis and degenerative arthritis account for the largest market share, driven by the increasing shift towards non-surgical and MI treatments.
By End User:
- Hospitals and Ambulatory Centers
- Research and Academic Institutes
- Dental Clinics and Facilities
- Orthopedic Clinics
Hospitals and ambulatory centers exhibit a clear dominance in the market on account of their ability to offer comprehensive care and advanced medical facilities.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the orthobiologics market, which can be attributed to the presence of high-quality healthcare infrastructure.
Orthobiologics Market Trends:
In 2024, the orthobiologics market is growing quickly due to key trends. The adoption of regenerative medicine techniques like platelet-rich plasma (PRP) and stem cell therapy is increasing, showing promising results for treating conditions like sports injuries, arthritis, and degenerative disc disease. The rise in chronic diseases like diabetes and obesity is also driving market growth, as these conditions can lead to musculoskeletal problems. As more people seek minimally invasive treatments, the demand for orthobiologics continues to grow. Advances in regenerative medicine, like stem cell therapy and tissue engineering, offer ways to repair tissues and improve healing. Additionally, there is a growing trend toward minimally invasive surgeries, which are supported by orthobiologics to reduce pain, speed up recovery, and lower risks.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145
